The State of Automated Insulin Delivery System: Research and Challenges

Maged Naser, Mohamed M. Nasr, Lamia H. Shehata

Abstract


Since the discovery of the existence-saving hormone insulin  through Dr Frederick Banting in 1921, there had been many integral discoveries and technical breakthroughs which have enabled people residing with type 1 diabetes (T1D) to live longer, more healthy lives. The development of insulin pumps, continuous glucose monitoring (CGM) systems, and automatic insulin delivery (AID) systems have enabled people living with T1D to safely manipulate their glucose, reduce their HbA1c, and improve their normal health and fantastic lifestyles. though, aid systems aren't but designed for absolutely everyone with T1D, and that they perform great during the overnight length while food and workout are not going on. (AID) systems are not fully computerized in that they require the individual using the machine to announce food and exercise to the system to avoid dangerous hyper- or hypoglycemia, respectively .


Keywords


State, Automated Insulin, Delivery System, Challenges.

Full Text:

PDF

References


- Pickup, John C., Melissa Ford Holloway, and Kritika Samsi. "Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives." Diabetes care 38.4 (2015): 544-550.

- Hirsch, Irl B. "Realistic expectations and practical use of continuous glucose monitoring for the endocrinologist." The Journal of Clinical Endocrinology & Metabolism 94.7 (2009): 2232-2238. [3]- Diabetes Research in Children Network (DirecNet) Study Group. "Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real‐time continuous glucose monitor (the FreeStyle Navigator)." Pediatric diabetes 9.2 (2008): 142-147.

- Messer, Laurel, et al. "Educating families on real time continuous glucose monitoring." The Diabetes Educator 35.1 (2009): 124-135.

- Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. "Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial." Diabetes care 33.1 (2010): 17-22.

- Evert, Alison, et al. "Continuous Glucose Monitoring Technology for Personal Use." The Diabetes Educator 35.4 (2009): 565-580.

- Laffel, Lori M., et al. "A practical approach to using trend arrows on the Dexcom G5 CGM system to manage children and adolescents with diabetes." Journal of the Endocrine Society 1.12 (2017): 1461-1476.

- Aleppo, Grazia, et al. "A practical approach to using trend arrows on the Dexcom G5 CGM system for the management of adults with diabetes." Journal of the Endocrine Society 1.12 (2017): 1445-1460.

- Battelino, Tadej, et al. "Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range." Diabetes care 42.8 (2019): 1593-1603.

- Messer, Laurel H., and Cari Berget. "Hybrid closed-loop systems to date: Hype versus reality." Diabetes Technology & Therapeutics 25.1 (2023): 91-94.

- Iturralde, Esti, et al. "Expectations and attitudes of individuals with type 1 diabetes after using a hybrid closed loop system." The Diabetes Educator 43.2 (2017): 223-232.

- Messer, Laurel H., Cari Berget, and Gregory P. Forlenza. "A clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm." Diabetes technology & therapeutics 21.8 (2019): 462-469.

- Messer, Laurel H., et al. "The dawn of automated insulin delivery: a new clinical framework to conceptualize insulin administration." Pediatric diabetes 19.1 (2018): 14-17.

- Messer, Laurel H., et al. "Optimizing hybrid closed-loop therapy in adolescents and emerging adults using the MiniMed 670G system." Diabetes Care 41.4 (2018): 789-796.

- Castañeda, Javier, et al. "Predictors of time in target glucose range in real‐world users of the MiniMed 780G system." Diabetes, Obesity and Metabolism 24.11 (2022): 2212-2221.

- Messer, Laurel H., and Marc D. Breton. "Therapy settings associated with optimal outcomes for t: slim X2 with control-IQ technology in real-world clinical care." Diabetes Technology & Therapeutics 25.12 (2023): 877-882.

- Russell, Steven J., Edward R. Damiano, and Peter Calhoun. "Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. Reply." The New England journal of medicine 388.4 (2023): 380-382.

- Russell, Steven J., et al. "Outpatient glycemic control with a bionic pancreas in type 1 diabetes." New England Journal of Medicine 371.4 (2014): 313-325.

- Gingras, Véronique, et al. "A simplified semiquantitative meal bolus strategy combined with single-and dual-hormone closed-loop delivery in patients with type 1 diabetes: a pilot study." Diabetes technology & therapeutics 18.8 (2016): 464-471.

- Petrovski, Goran, et al. "Simplified meal announcement versus precise carbohydrate counting in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed loop system: a randomized controlled trial comparing glucose control." Diabetes Care 46.3 (2023): 544-550.

- Corbett, John P., et al. "Smartwatch gesture‐based meal reminders improve glycaemic control." Diabetes, Obesity and Metabolism 24.8 (2022): 1667-1670.

- Roy, Anirban, et al. "An automated insulin delivery system with automatic meal bolus based on a hand-gesturing algorithm." Diabetes technology & therapeutics 26.9 (2024): 633-643.

- Messer, Laurel H., et al. "Smartphone bolus feature increases number of insulin boluses in people with low bolus frequency." Journal of Diabetes Science and Technology 18.1 (2024): 10-13.

- Paterson, M. A., et al. "Impact of dietary protein on postprandial glycaemic control and insulin requirements in type 1 diabetes: a systematic review." Diabetic Medicine 36.12 (2019): 1585-1599.

- Scidà, Giuseppe, et al. "Postprandial glucose control with different hybrid closed-loop systems according to type of meal in adults with type 1 diabetes." Journal of Diabetes Science and Technology 19.5 (2025): 1331-1340.

- Vetrani, Claudia, et al. "Dietary determinants of postprandial blood glucose control in adults with type 1 diabetes on a hybrid closed-loop system." Diabetologia 65.1 (2022): 79-87.

- Shalit, Roy, et al. "Unannounced meal challenges using an advanced hybrid closed-loop system." Diabetes Technology & Therapeutics 25.9 (2023): 579-588.

- Royston, Chloë, et al. "Impact of ultra-rapid insulin on boost and ease-off in the Cambridge hybrid closed-loop system for individuals with type 1 diabetes." Journal of Diabetes Science and Technology (2024): 19322968241289963.

- Haliloglu, Belma, et al. "Postprandial glucose excursions with ultra-rapid insulin analogs in hybrid closed-loop therapy for adults with type 1 diabetes." Diabetes Technology & Therapeutics 26.7 (2024): 449-456.

- Ware, Julia, et al. "Hybrid closed-loop with faster insulin aspart compared with standard insulin aspart in very young children with type 1 diabetes: a double-blind, multicenter, randomized, crossover study." Diabetes Technology & Therapeutics 25.6 (2023): 431-436.

- Grosman, Benyamin, et al. "Fast-acting insulin aspart (Fiasp®) improves glycemic outcomes when used with MiniMedTM 670G hybrid closed-loop system in simulated trials compared to NovoLog®." Computer Methods and Programs in Biomedicine 205 (2021): 106087.

- Hsu, Liana, et al. "Fast-acting insulin aspart use with the MiniMedTM 670G system." Diabetes technology & therapeutics 23.1 (2021): 1-7.

- Boughton, Charlotte K., et al. "Hybrid closed‐loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: a double‐blind, multicentre, multinational, randomized, crossover study." Diabetes, Obesity and Metabolism 23.6 (2021): 1389-1396.

- Levy, Carol J., et al. "Multicenter evaluation of ultra-rapid lispro insulin with control-IQ technology in adults, adolescents, and children with type 1 diabetes." Diabetes technology & therapeutics 26.9 (2024): 652-660.

- Cohen, Elisa, et al. "Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada." The Lancet Digital Health 6.7 (2024): e489-e499.

- Haidar, Ahmad, et al. "Reducing the need for carbohydrate counting in type 1 diabetes using closed‐loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non‐inferiority, crossover pilot trial." Diabetes, Obesity and Metabolism 23.6 (2021): 1272-1281.

- Breton, Marc, et al. "Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia." Diabetes 61.9 (2012): 2230-2237.

- Turksoy, Kamuran, et al. "Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement." Diabetes technology & therapeutics 15.5 (2013): 386-400.

- Breton, Marc D., et al. "Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes." Diabetes technology & therapeutics 16.8 (2014): 506-511.

- Turksoy, Kamuran, et al. "An integrated multivariable artificial pancreas control system." Journal of diabetes science and technology 8.3 (2014): 498-507.

- Turksoy, Kamuran, et al. "An integrated multivariable artificial pancreas control system." Journal of diabetes science and technology 8.3 (2014): 498-507.

- Castle, Jessica R., et al. "Randomized outpatient trial of single-and dual-hormone closed-loop systems that adapt to exercise using wearable sensors." Diabetes care 41.7 (2018): 1471-1477.

- Jacobs, Peter G., et al. "Randomized trial of a dual‐hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor‐augmented pump therapy." Diabetes, Obesity and Metabolism 18.11 (2016): 1110-1119.

- Jacobs, Peter G., et al. "Incorporating an exercise detection, grading, and hormone dosing algorithm into the artificial pancreas using accelerometry and heart rate." Journal of diabetes science and technology 9.6 (2015): 1175-1184.

- Jacobs, Peter G., et al. "Integrating metabolic expenditure information from wearable fitness sensors into an AI-augmented automated insulin delivery system: a randomised clinical trial." The Lancet Digital Health 5.9 (2023): e607-e617.

- Wilson, Leah M., et al. "Dual-hormone closed-loop system using a liquid stable glucagon formulation versus insulin-only closed-loop system compared with a predictive low glucose suspend system: an open-label, outpatient, single-center, crossover, randomized controlled trial." Diabetes Care 43.11 (2020): 2721-2729.

- Sherr, Jennifer L., et al. "Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes." Diabetes care 36.10 (2013): 2909-2914.

- Jayawardene, Dilshani C., et al. "Closed-loop insulin delivery for adults with type 1 diabetes undertaking high-intensity interval exercise versus moderate-intensity exercise: a randomized, crossover study." Diabetes technology & therapeutics 19.6 (2017): 340-348.

- Lee, Melissa H., et al. "Glucose and counterregulatory responses to exercise in adults with type 1 diabetes and impaired awareness of hypoglycemia using closed-loop insulin delivery: a randomized crossover study." Diabetes Care 43.2 (2020): 480-483.

- Seckold, Rowen, et al. "A comparison of glucose and additional signals for three different exercise types in adolescents with type 1 diabetes using a hybrid closed-loop system." Diabetes Technology & Therapeutics 27.4 (2025): 308-322.

- Paldus, Barbora, et al. "Strengths and challenges of closed-loop insulin delivery during exercise in people with type 1 diabetes: potential future directions." Journal of Diabetes Science and Technology 17.4 (2023): 1077-1084.

- Lei, Mengyun, et al. "The efficacy of glucose‐responsive insulin and glucagon delivery on exercise‐induced hypoglycaemia among adults with type 1 diabetes mellitus: A meta‐analysis of randomized controlled trials." Diabetes, Obesity & Metabolism 26.4 (2024).

- Moser, Othmar, et al. "The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)." Diabetologia 68.2 (2025): 255-280.

- Jacobs, Peter G., et al. "An evaluation of how exercise position statement guidelines are being used in the real world in type 1 diabetes: findings from the type 1 diabetes exercise initiative (T1DEXI)." Diabetes Research and Clinical Practice 217 (2024): 111874.

- Frank, Spencer, et al. "Modeling the acute effects of exercise on insulin kinetics in type 1 diabetes." Journal of pharmacokinetics and pharmacodynamics 45.6 (2018): 829-845.

- Nguyen, Thanh-Tin P., et al. "Separating insulin-mediated and non-insulin-mediated glucose uptake during and after aerobic exercise in type 1 diabetes." American Journal of Physiology-Endocrinology and Metabolism 320.3 (2021): E425-E437.

- Young, Gavin M., et al. "Quantifying insulin-mediated and noninsulin-mediated changes in glucose dynamics during resistance exercise in type 1 diabetes." American Journal of Physiology-Endocrinology and Metabolism 325.3 (2023): E192-E206.

- Alkhateeb, Haneen, et al. "Modelling glucose dynamics during moderate exercise in individuals with type 1 diabetes." Plos one 16.3 (2021): e0248280.

- Romeres, Davide, et al. "Exercise effect on insulin-dependent and insulin-independent glucose utilization in healthy individuals and individuals with type 1 diabetes: a modeling study." American Journal of Physiology-Endocrinology and Metabolism (2021).

- Hobbs, Nicole, et al. "A physical activity-intensity driven glycemic model for type 1 diabetes." Computer Methods and Programs in Biomedicine 226 (2022): 107153.

- Ozaslan, Basak, et al. "Safety and feasibility evaluation of step count informed meal boluses in type 1 diabetes: a pilot study." Journal of Diabetes Science and Technology 16.3 (2022): 670-676.

- Askari, Mohammad Reza, et al. "Meal and physical activity detection from free-living data for discovering disturbance patterns of glucose levels in people with diabetes." BioMedInformatics 2.2 (2022): 297-317.

- Mosquera-Lopez, Clara, and Peter G. Jacobs. "Incorporating glucose variability into glucose forecasting accuracy assessment using the new glucose variability impact index and the prediction consistency index: An LSTM case example." Journal of Diabetes Science and Technology 16.1 (2022): 7-18.

- Shetty, Vinutha B., et al. "Effect of exercise intensity on glucose requirements to maintain euglycemia during exercise in type 1 diabetes." The Journal of Clinical Endocrinology & Metabolism 101.3 (2016): 972-980.

- Riddell, Michael C., et al. "Exercise and the development of the artificial pancreas: one of the more difficult series of hurdles." Journal of diabetes science and technology 9.6 (2015): 1217-1226.

- Riddell, Michael C., and Anne L. Peters. "Exercise in adults with type 1 diabetes mellitus." Nature Reviews Endocrinology 19.2 (2023): 98-111.

- Manrique, Camila, Guido Lastra, and James R. Sowers. "New insights into insulin action and resistance in the vasculature." Annals of the New York Academy of Sciences 1311.1 (2014): 138-150.

- Mallad, Ashwini, et al. "Exercise effects on postprandial glucose metabolism in type 1 diabetes: a triple-tracer approach." American Journal of Physiology-Endocrinology and Metabolism 308.12 (2015): E1106-E1115.

- Rickels, Michael R., et al. "Mini-dose glucagon as a novel approach to prevent exercise-induced hypoglycemia in type 1 diabetes." Diabetes Care 41.9 (2018): 1909-1916.

- Taleb, Nadine, et al. "Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial." Diabetologia 59.12 (2016): 2561-2571.

- Lundemose, Sissel Banner, et al. "Is low‐dose glucagon needed and effective in preventing fasted exercise‐induced hypoglycaemia in type 1 diabetes treated with the MiniMed 780G, an automated insulin delivery system?." Diabetes, Obesity and Metabolism 27.3 (2025): 1164-1171.

- Hobbs, Nicole, et al. "Observational study of glycemic impact of anticipatory and early-race athletic competition stress in type 1 diabetes." Frontiers in Clinical Diabetes and Healthcare 3 (2022): 816316.

- Morrison, Dale, et al. "Comparable glucose control with fast-acting insulin aspart versus insulin aspart using a second-generation hybrid closed-loop system during exercise." Diabetes Technology & Therapeutics 24.2 (2022): 93-101.

- Askari, Mohammad Reza, et al. "Multivariable automated insulin delivery system for handling planned and spontaneous physical activities." Journal of Diabetes Science and Technology 17.6 (2023): 1456-1469.

- Young, Gavin, et al. "Design and in silico evaluation of an exercise decision support system using digital twin models." (2024): 324-334.

- O'Malley, Grenye, et al. "Longitudinal observation of insulin use and glucose sensor metrics in pregnant women with type 1 diabetes using continuous glucose monitors and insulin pumps: the LOIS-P study." Diabetes technology & therapeutics 23.12 (2021): 807-817.

- Brown, Sue A., et al. "Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes." New England Journal of Medicine 381.18 (2019): 1707-1717.

- García-Patterson, Apolonia, et al. "Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction." Diabetologia 53.3 (2010): 446-451.

- Kampmann, Ulla, et al. "Determinants of maternal insulin resistance during pregnancy: an updated overview." Journal of diabetes research 2019.1 (2019): 5320156.

- ElSayed, Nuha A., et al. "15. Management of diabetes in pregnancy: standards of care in diabetes—2023." Diabetes care 46.Supplement_1 (2023): S254-S266.

- Marcinkevage, Jessica A., and KM Venkat Narayan. "Gestational diabetes mellitus: taking it to heart." Primary Care Diabetes 5.2 (2011): 81-88.

- Ozaslan, Basak, et al. "Zone-MPC automated insulin delivery algorithm tuned for pregnancy complicated by type 1 diabetes." Frontiers in Endocrinology 12 (2022): 768639.

- Feig, Denice S., et al. "Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial." The Lancet 390.10110 (2017): 2347-2359.

- Feig, Denice S., et al. "Pumps or multiple daily injections in pregnancy involving type 1 diabetes: a prespecified analysis of the CONCEPTT randomized trial." Diabetes Care 41.12 (2018): 2471-2479.

- Benhalima, Katrien, et al. "Automated insulin delivery for pregnant women with type 1 diabetes: where do we stand?." Journal of diabetes science and technology 18.6 (2024): 1334-1345.

- Lawton, Julia, et al. "Listening to women: experiences of using closed-loop in type 1 diabetes pregnancy." Diabetes Technology & Therapeutics 25.12 (2023): 845-855.

- Benhalima, Katrien, and Sarit Polsky. "Automated insulin delivery in pregnancies complicated by type 1 diabetes." (2025): 19322968251323614.

- Yang, Kaijie, et al. "Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019: population based study." Bmj 385 (2024).

- Munshi, Medha, et al. "Use of technology in older adults with type 1 diabetes: clinical characteristics and glycemic metrics." Diabetes technology & therapeutics 24.1 (2022): 1-9.

- Munshi, Medha N., et al. "Continuous glucose monitoring with geriatric principles in older adults with type 1 diabetes and hypoglycemia: a randomized controlled trial." Diabetes Care 48.5 (2025): 694-702.

- Beck, Roy W., et al. "A meta-analysis of randomized trial outcomes for the t: slim X2 insulin pump with control-IQ technology in youth and adults from age 2 to 72." Diabetes Technology & Therapeutics 25.5 (2023): 329-342.

- Olsen, S. E., et al. "Hypoglycaemia symptoms and impaired awareness of hypoglycaemia in adults with type 1 diabetes: the association with diabetes duration." Diabetic medicine 31.10 (2014): 1210-1217.

- Olsen, S. E., et al. "Hypoglycaemia symptoms and impaired awareness of hypoglycaemia in adults with type 1 diabetes: the association with diabetes duration." Diabetic medicine 31.10 (2014): 1210-1217.

- Shah, Viral N., et al. "Severe hypoglycemia is associated with high risk for falls in adults with type 1 diabetes." Archives of osteoporosis 13.1 (2018): 66.

- Shah, Viral N. "bone health in type 1 and type 2 diabetes: current knowledge and future direction." Current Opinion in Endocrinology, Diabetes and Obesity 28.4 (2021): 337-339.

- Pratley, Richard E., et al. "Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial." Jama 323.23 (2020): 2397-2406.

- Miller, Kellee M., et al. "Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes." Diabetes technology & therapeutics 24.6 (2022): 424-434.

- Boughton, Charlotte K., et al. "Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study." The Lancet Healthy Longevity 3.3 (2022): e135-e142.

- Kudva, Yogish C., et al. "Automated insulin delivery in older adults with type 1 diabetes." NEJM evidence 4.1 (2025): EVIDoa2400200.

- Daly, Aideen B., et al. "Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial." Nature medicine 29.1 (2023): 203-208.

- Borel, Anne-Laure, et al. "Closed-loop insulin therapy for people with type 2 diabetes treated with an insulin pump: a 12-week multicenter, open-label randomized, controlled, crossover trial." Diabetes Care 47.10 (2024): 1778-1786.

- Bhargava, Anuj, et al. "Safety and Effectiveness of MiniMedTM 780G Advanced Hybrid Closed-Loop Insulin Intensification in Adults with Insulin-Requiring Type 2 Diabetes." Diabetes Technology & Therapeutics 27.5 (2025): 366-375.

- Levy, Carol J., et al. "Beneficial effects of control-IQ automated insulin delivery in basal-bolus and basal-only insulin users with type 2 diabetes." Clinical Diabetes 42.1 (2024): 116-124.

- Pasquel, Francisco J., et al. "Automated insulin delivery in adults with type 2 diabetes: A nonrandomized clinical trial." JAMA Network Open 8.2 (2025): e2459348-e2459348.

- Fabris, Chiara, and Boris Kovatchev. "Real-life use of automated insulin delivery in individuals with type 2 diabetes." Journal of Diabetes Science and Technology (2024): 19322968241274786.

- Forlenza, Gregory P., et al. "Real-world evidence supporting tandem control-IQ hybrid closed-loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations." Diabetes technology & therapeutics 24.11 (2022): 814-823.

- Chakrabarty, Ankush, et al. "Embedded model predictive control for a wearable artificial pancreas." IEEE Transactions on Control Systems Technology 28.6 (2019): 2600-2607.

- Dassau, Eyal, et al. "Clinical evaluation of a personalized artificial pancreas." Diabetes care 36.4 (2013): 801-809.

- Fushimi, Emilia, et al. "Artificial pancreas: Evaluating the ARG algorithm without meal announcement." Journal of Diabetes Science and Technology 13.6 (2019): 1035-1043.

- Gondhalekar, Ravi, Eyal Dassau, and Francis J. Doyle III. "Velocity-weighting & velocity-penalty MPC of an artificial pancreas: Improved safety & performance." Automatica 91 (2018): 105-117.

- Lee, Joon Bok, et al. "Enhanced model predictive control (eMPC) strategy for automated glucose control." Industrial & engineering chemistry research 55.46 (2016): 11857-11868.

- Colmegna, Patricio, et al. "Automatic regulatory control in type 1 diabetes without carbohydrate counting." Control engineering practice 74 (2018): 22-32.

- Shi, Dawei, Eyal Dassau, and Francis J. Doyle. "Adaptive zone model predictive control of artificial pancreas based on glucose-and velocity-dependent control penalties." IEEE Transactions on Biomedical Engineering 66.4 (2018): 1045-1054.

- Dassau, Eyal, et al. "Twelve-week 24/7 ambulatory artificial pancreas with weekly adaptation of insulin delivery settings: effect on hemoglobin A1c and hypoglycemia." Diabetes Care 40.12 (2017): 1719-1726.

- Cameron, Faye M., et al. "Closed-loop control without meal announcement in type 1 diabetes." Diabetes technology & therapeutics 19.9 (2017): 527-532.

- Forlenza, Gregory P., et al. "Fully closed-loop multiple model probabilistic predictive controller artificial pancreas performance in adolescents and adults in a supervised hotel setting." Diabetes technology & therapeutics 20.5 (2018): 335-343.

- Jacobs, Peter G., and Clara Mosquera-Lopez. "Artificial Intelligence in Automated Hormone Delivery." Diabetes Digital Health, Telehealth, and Artificial Intelligence. Academic Press, 2024. 329-340.

- Moscoso-Vasquez, Marcela, et al. "Evaluation of an automated priming bolus for improving prandial glucose control in full closed loop delivery." Diabetes Technology & Therapeutics 27.2 (2025): 93-100.

- Garcia-Tirado, Jose, et al. "Advanced closed-loop control system improves postprandial glycemic control compared with a hybrid closed-loop system following unannounced meal." Diabetes Care 44.10 (2021): 2379-2387.

- Garcia-Tirado, Jose, et al. "Assessment of meal anticipation for improving fully automated insulin delivery in adults with type 1 diabetes." Diabetes Care 46.9 (2023): 1652-1658.

- Boughton, Charlotte K., et al. "Fully closed-loop glucose control compared with insulin pump therapy with continuous glucose monitoring in adults with type 1 diabetes and suboptimal glycemic control: a single-center, randomized, crossover study." Diabetes Care 46.11 (2023): 1916-1922.

- Boughton, Charlotte K., et al. "Implementation of fully closed‐loop insulin delivery for inpatients with diabetes: real‐world outcomes." Diabetic Medicine 40.6 (2023): e15092.

- Dovc, Klemen, et al. "Faster compared with standard insulin aspart during day-and-night fully closed-loop insulin therapy in type 1 diabetes: a double-blind randomized crossover trial." Diabetes Care 43.1 (2020): 29-36.

- Elian, Viviana, et al. "Risks and benefits of SGLT-2 inhibitors for type 1 diabetes patients using automated insulin delivery systems—a literature review." International Journal of Molecular Sciences 25.4 (2024): 1972.

- Holmager, Pernille, et al. "GLP-1 receptor agonists in overweight and obese individuals with type 1 diabetes using an automated insulin delivery device: a real-world study." (2025): 286-291.

- Shah, Viral N., et al. "Consensus report on glucagon-like peptide-1 receptor agonists as adjunctive treatment for individuals with type 1 diabetes using an automated insulin delivery system." Journal of diabetes science and technology 19.1 (2025): 191-216.

- Sherr, Jennifer L., et al. "Mitigating meal-related glycemic excursions in an insulin-sparing manner during closed-loop insulin delivery: the beneficial effects of adjunctive pramlintide and liraglutide." Diabetes care 39.7 (2016): 1127-1134.

- Tsoukas, Michael A., et al. "A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial." The Lancet Digital Health 3.11 (2021): e723-e732.

- Van Bon, A. C., et al. "Bihormonal fully closed-loop system for the treatment of type 1 diabetes: a real-world multicentre, prospective, single-arm trial in the Netherlands." The Lancet Digital Health 6.4 (2024): e272-e280.

- Tanenbaum, Molly L., et al. "‘We're taught green is good’: Perspectives on time in range and time in tight range from youth with type 1 diabetes, and parents of youth with type 1 diabetes." Diabetic Medicine 41.12 (2024): e15423.

- Shah, Viral N., et al. "Time in range is associated with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study." Diabetes Technology & Therapeutics 26.4 (2024): 246-251.

- Lobo, Benjamin, et al. "The association of time-in-range and time-in-tight-range with retinopathy progression in the virtual diabetes control and complications trial continuous glucose monitoring dataset." Diabetes Technology & Therapeutics (2025).

- Beck, Roy W., et al. "A comparison of continuous glucose monitoring-measured time-in-range 70–180 mg/dL versus time-in-tight-range 70–140 mg/dL." Diabetes Technology & Therapeutics 26.3 (2024): 151-155.

- Mathieu, Chantal, et al. "The health economics of automated insulin delivery systems and the potential use of time in range in diabetes modeling: a narrative review." Diabetes Technology & Therapeutics 26.S3 (2024): 66-75.




DOI: http://dx.doi.org/10.52155/ijpsat.v55.1.7758

Refbacks

  • There are currently no refbacks.


Copyright (c) 2025 Maged Naser

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.